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~Tha Mechanism of  In Endothel ial  Improvement 
Function by Pravastatln: Direct Effect or Through 
Cholesterol  Lowering 
R,A, Vogel, M,C, Correttt, G,D, Plotnick, University of Marylnnd School ot 
M~ll(~lne, ~sltlmom, M~lryland, LISA 
B~ckgrogn¢ Cflnlcol trials of cholesterol owering using HMG.CoA reduotasa 
Inhlblto~ have demonstrated vow early mdu~tlons tn oardlovasoutar events 
raising the question of whether these agent~ directly affect vascular biology, 
possibly tndopecdont of their ~hotostorol lowering propodlos, 
Ml~thod~" To determine whether on HMG,CoA reductsso Inhibitor, proves. 
tails, improves endothelial function Independent el Its effect on ohotostoml, 
we maaeumd flow. mediated brachiat adeW vasodllatlon using hlgh.roaolu. 
tton ultrasound bolero and slier 1 day, 1, ~, 4, ¢'md t2 weeks of administration 
of pravnststln 20 mgld~y in 7 healthy, normocholestarolemlo, middle.sUed 
loon, 
R~glt~: Total and LOL.gholosteml tell altar P. weeks el provastatin sdmin. 
tsttatlon from 198 I 15 and 131 ~ 15 mgldL respectively, to 162 ~ ~2 and 
96 :t 13 mgldl (p - 0,01), No nddtkonal reductions in cholesterol worn ob. 
sowed altar 12 weeks of treatment, Flew.mediated vasodllatton, measured 
as peroont dlamotor change, increased significantly only after 2 weeks of 
treatment', baseline 7 ~ 3%, 1 day 7 ± 3%, 1 week 10 :t 3%, 2 weeks 13 t. 
3% (p ~ 0,01), 4 weeks 12 ~ 2% (p ~. 0.01), nnd 12 weeks f4 ~ 5% (p ~. 
001) 
Conclusions: Those data confirm that (~holostorot lowering by the HMG- 
CoA roducfsse inhibitor pravastatln rapidly improves endothelial function, 
but tlndll that no vascular blologlcat affect is ohsn~ed before significant 
cholesterol owering occum. These data sttggost hat pravastatln improves 
endothellol function through a cholesterol-lowering rather than a direct effect. 
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F'~-6- '~ Short-term Aggreaelve LDL-Lowerlng, 
Endothelial-mediated Arterloiar Vesodl iatst lon and 
Capillary Permeabil ity In Patients With 
Atheresclerotlc Vascular Disease 
G Dell'grog ~ , S Bandlnelli ~, G Ponno ~, R Navatesi 2, R Podrtnolli ~ 'I 
Clinics Medea, Italy: Oiabetologia, Universita' di Piss, Italy 
E~ckground: Although consistent evidence shows an improvement of ederi- 
olar endothelial function after aggmsslvo LDL cholesterol (LDLc~o~)-Ioworing, 
less croat is how early this change takes place, In addition, it te unknown the 
effect ot lowering cholesterol on the function of the ondothelium located at 
the capLIlan/bed whom most of the endothollat coils am contained. 
Material & Methods: (MEANS ¢ SD): High.dose (40 rag/die) stmvastatin 
iS) was administered for one month in fourteon non diabetic (glucose: 99 
:, 14 mojdl. HbAtc: 5,7 ± 0.4%), normotenslve (ASPM..,t,,: 124:1:11/74 ± 
7 mmHg) males (age: 58 ,~: 5 yrs) with athemsclemtic peripheral vascular 
disease and LDl..c.o~ ~ 130 mg/dl (166 ~: 38 mg/dl). Evaluation variables 
were I. Forearm vasodilatation [% forearm blood Ilow (FeF, ml/min/dl, venous 
ptethysmography) cha=lges Imm baseline] to ietrearterial acetylcheline (ACH, 
7.5, 15, 30 s~g/min x 5 minutes each), an endothelial-mediated vasodilator, 2. 
Transcapillary albumin escape rote (TERse, °,Jhr, the one-hour decline rate 
of i.v. ~;sl-albumin), a measure of macmmolecular permeability of capillary 
ondothotium, 3. Maximum fomam'~ vasoditatation (peak FBF after 13.minute 
ischomia) to account for non specific vasodilator mechanisms. 
Results: (Means ± SD): S reduced LDL cho~ by 39% (to 101 ~: 32 mg/dl, 
p .. 0,0001) without significant changes in the response to ACH (+180 ~ 24, 
27'3 ± ?0, 419 ± 67% vs 230 ± 57%, 309 ± 86, 461 ~. 65%); on the contrary, 
TER,~It, decreased tram 10.4 ± 1.9 to 8.7 ± 2.9 (p -~ 0.05). Postischemic FBF 
(59.3 ± 13 vs 58.7 ± 13 ml/min/dl) was stable. 
Conclusions: Improvement of arteriolar endothelial function is still incon- 
sistent after one-month S therapy, in spite of drastic LDl..c~,o~ reduction. The 
statistically significant reduction in TER .~ by S over the same treatment 
period indicates the influence el LDI.<,o= on systemic capillary permeability, 
and suggests that changes in capillary and arteriolar function may follow 
rather different ime-ceurses, 
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~'~ Acute Choleaterol  Leukocyte Reduction Decreases 
Adhesiveness end Improves Peripheral 
Microcireulatory Function in Patients With Familial 
Hypercholesterolemla 
1", Sampintto, C. Palombo, G, Blgalll, M. Ferdeghini, A, Ctardi, M, Koz&kov&, 
M, Taddoi, M. Tuonl, A, Blonde, CNR Inslttute of Clinical Physiology P/n: 
Institute of Clinical Medicine, University of PiN, Italy 
Background: in hypemhote~tomlemla, animpairment of endothelium-depen. 
dent vasodllatlon has boon demonstrated oven in arteries free from atlteto. 
sclomtio atonosia, Whether or not high plasma cholesterol (CH) per ae may 
lend to endothelial damape i~ still debated, 
Aim of the Study: to Investigate the relations between CH, leukecyle 
adhesiveness and poflphomt mlcroclmulsloq/blood flow in a clinical model 
el hyparcholeotemlemta undergoing sharp CH venations, 
Methods: In 8 patients with familial hypercho!astemlemia (FH) under- 
going LDL.aphomaia treatment, serum lipide, plaoma intercellular adhesion 
molec~llo (slCAM1), endefhetium leukocyte adhesion molecule (sELAM1), 
tnftammafton and ooagulation indexes were determined I~tom, soon after 
and 2 end 6 days allot aphamsia, At the some time, skin blood flow at 
s lower oKtmmity was measured by Laser Doppler bafom and after I(~¢e~ 
thermio stimulation at 44 ~, 
Restllt~: LDL-aphero=~is reduced CH, CH.LDL, ape B, TG and Lp(a) 
by 74%, 82%, 79%, 66%, 86%, respectively, slCAMt and sELAMt betoce 
aphemsts whore higher than in healthy controls, and decmssed after .but 
not by. aphoresls (p • 0,0011, Individual sICAMt and sELAMt 10elgin and 
after aphemsis whom poslkvoty cormlatnd with CH(p -~ 0.001 and < 0.02). 
Resting and stimulated skin blood flow in FH was slgeilceantly lower than 
in normal controls before, and refumed to normal alter epheresis. All van+ 
ables were still Improved after 2 days. The rebound curves of CH, adhesion 
molecules and microclm~h~toW blood flow were positively co~elate<l each 
other. No changes in inflammation and coagulation factors were found. 
Conclusion: in FH, acute end massive CH Iowenng is paralleled by down- 
regulation of endothelial adhssivanese and msto,ng of normal penpheml 
microclmulatory function, supporting the hypothesis of a direct, reversible. 
endothelial dysfunction due to high plasma CH. 
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[80"~ Oxid ized Low Density L lpoprote ln  Enhances 
Anoxia-Reoxygenet lon-mediated Apoptosis  in 
Cultured Human Coronary  Artery Endothelial Cells 
D. Li, B. Yang, J.L. Mehta. University of Florida and the VA Medtcal Center. 
Gainesvilte, Fiends, USA 
Low density lipopmteins (ox-LDL) am atherogenic and high levels el ox-LDL 
am associated with la~e infarcts following coronary aries/occlusion and 
mpedusion. Other studies show that cardiomyocyles tmdergo apoptosis 
upon ischemia-mperfusion, perhaps a result el free radical mtease. We 
have recently found that anoxia-moxygenation results in about 20-30% 
apoptosis in cultured human coronary artery endothelial cells (HCAECs), 
and the magnitude ot apoptosis is increased by coincubation o1 HCAECs 
with TNF~. To determine if ox-LDL increases injury to HCAECs during 
anoxia (24 hm)-moxygenation (3 hm), HCAECs were incubated with na- 
tive or ox.LDL and TNF¢~r. Cellular injury was quantitated by measunng LDH 
release. TUNEL, DNA ladder and electron microscopy were used to deter. 
mine changes characteristic o! apoptosis. Presence o1 ox-LDL (20 14oJml) 
inc=eased number of apoptotic cells (40.1 ± 8.8 vs 27.1 + 3.1% tn cells 
exposed to anoxia-reoxygenation alone, P .  0.01). TNF~ (20 ng/mt) further 
increased the effect of ox-LDL (number o1 apoptotic ells 61.8 ± 144 vs 40.1 
8.8. P < 0.01). Low concentrations o1 ox-LDL (1-5 l,g/ml) and native-LDL 
(20 .t~g/ml) under identical conditions did not increase apoptosis. Treatment 
of cells with ox-LDL (20 l~gtml) or ox-LDL (20 .gfml) + TNF=~ (20 ng/ml) 
markedly decreased supemxide dismutase activity (3.67 ± 0.46 and 3.59 
0.64 vs 4.55 ~ 0.17 units/ml in anoxia-moxygenation alone, P ± 0.01) 
and increased the release of LDH. These data indicate thai the toxicity of 
ox-LDL in cultured HCAECs in vitro involves apoptosis. Cx-LDL also aug- 
ments injury to cultured HCAECs during anoxra-reoxygenation, perhaps by 
decreasing endogenous antioxidant activity. 
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1 806-5~ Reversal  of Impaired Endothel ium-dependent 
Vasodilatation In Apollpoprotein E-deficient Mice by 
Recombinant  Apol lpoprote in A'lM,ano 
B.D. Coin, P.K. Shah, J. Yano, M.D. Molloy, S. Cemek, S. Kdul. 
Cedars-Sinai Medical Center, Los Angeles, CA, USA 
We used an atherogenic ApoE-deficient mouse (ApoE KO) model to deter- 
